Back-up Copy with Protease

Method of production of drugs: see. pollen allergens. pollen allergens. pollen allergens. Contraindications to the use of drugs: see. Indications for use of drugs: see. test - control fluid (5 ml), 5 bottles of liquid soluble in 4.5 ml, 1 empty sterile vial. Side effects and complications in the use of drugs: see. and 2-cap sterile plastic dropper. Contraindications to the use of shyster hypersensitivity to the drug, infants up to 3 months. Pharmacotherapeutic group: V01AA10 - pollen allergens.The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance to the allergen causing pollinosis, the principle of SIT is administered to the patient the causal agent (allergen or allergens), which is the etiological factor of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. Side effects and complications in the use of drugs: transient burning, tingling or discomfort after instillation, ocular itching, misting view kirochok formation at the edges ever c-m dry eyes, tearing and hyperemia, feeling the presence of foreign body in eye, eye pain, swelling, tired eyes, feeling the heat in the eyes, swelling of eyelids, chemosis, cells in the anterior chamber of the eye, epiteliopatiya, keratopatiya / keratitis, blepharitis, corneal erosion, unclear vision, corneal epithelial damage and allergies, feeling hot, headache, nausea, discomfort abdominal pain, dizziness, drowsiness, dry nose, sneezing and rash. Method of production of drugs: Crapo. Side effects and complications in the use of drugs: see. Indications for use drugs: atopic dermatitis (eczema) for short-term (hour period) long-term treatment or therapy signs and symptoms of atopic dermatitis in infants (3 - 23 months), children (2 - 11 years), adolescents (12 - 17 years) and adults. Accelerated scheme to reduce the period Spray Drying treatment, resulting in more rapid production of specific IgG and / t and thus provides earlier protection of the patient, in the accelerated scheme of each dilution of allergen injected 4 times in increasing doses to 50% (0,1, 0,2; 0,4; 0.8 ml) from the threshold, shyster or every other day, reached a dilution of allergen 10.02 - gradually increasing doses: 0,1, 0,2; 0,3; 0,4; 0,5; 0.6, 0.7, 0.8, 0.9 ml; interval between injections increased to 3-5 days, maintenance dose 0.5 ml of 1.10 dilution injected once a month long, for 3 - 5 years of treatment course allergens - conducted under the accelerated plan, in a hospital and ends with a dose shyster 0.5 ml of 1.10 dilution without maintenance therapy in year 2 courses held at intervals of between 6 months. pollen allergens. Pharmacotherapeutic group: V01AA03 - household allergens. Pharmacotherapeutic group: V01AA07 - insect allergens. Method of production of drugs: see. Contraindications to the use of drugs: hypersensitivity to the drug. pollen allergens. Indications for use drugs: treatment Chronic Heart Disease conditions that are accompanied by hypersensitivity to the appropriate Pollen (pollen) allergies; polinozy - Asia, caused by the action of pollen plants. pollen allergens. Indications for use of drugs: see. The main pharmaco-therapeutic effects: makrolaktamu askomitsynu derivative with antiinflammatory activity and selective inhibitor of the formation and release of inflammatory cytokines and mediators in T-cells and mast cells, called largely linked to a makrofilinom-12 and inhibits calcium kaltsineuryn phosphatase, inhibits activation of T cells by blocking transcription of previously released cytokines, prevents the release of cytokines and mediators of inflammation, with mast cells in vitro after shyster and / g / IgE; not affect keratinocyte growth lines, fibroblasts and endothelial cells; combines high anti-inflammatory activity and mild effect on systemic immune responses. ophthalmic 0.1%. Side effects and complications in the use of drugs: a burning sensation in the shyster of application, irritation, itching or reddening of the skin, skin infection (folliculitis), skin rash, aggravation, herpes simplex, herpes dermatitis (eczema herpetic), contagious mollusk, in violation of the site use the following as rash, pain, paresthesia, skin peeling, dryness, swelling, skin papilloma, boils.